Gilles de la Tourette syndrome in Central Africa: A case report
Advances in General Practice of Medicine · 2022
DOI: 10.25082/agpm.2022.01.006 ↗Kurz gefasst
Fallbericht in der Zeitschrift Advances in General Practice of Medicine, 2022. Verfasst von Marcellin Bugeme und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Gilles de la Tourette syndrome (GTS), also known as Tourette disorder or Tourette syndrome, is a neurodevelopmental disorder that is characterized by the presence of multiple motor and one or more vocal/phonic tics. These tics are generally more common during childhood and reach a maximum severity between 10 and 12 years. Ticks tend to decrease during late adolescence and adulthood in a majority of patients. We report an observation of GTS diagnosed in a 12-year-old child who was taken care of by clonazepam with a good improvement in its symptomatology. This condition has been reported only very rarely in black sub-Saharan Africans and this is probably the first case of GTS reported in Central Africa.
Zitieren
APA
Bugeme, M., Affognon, K. C. C., Musung, J. M., Omanjelo, F. S., Teuwen, D. E., Numbi, S. K., Ndua, J. T., Mukuku, O., & Muyumba, E. K. (2022). Gilles de la Tourette syndrome in Central Africa: A case report. Advances in General Practice of Medicine. https://doi.org/10.25082/agpm.2022.01.006
Vancouver
Bugeme M, Affognon KCC, Musung JM, Omanjelo FS, Teuwen DE, Numbi SK, et al. Gilles de la Tourette syndrome in Central Africa: A case report. Advances in General Practice of Medicine. 2022. doi:10.25082/agpm.2022.01.006
BibTeX
@article{Bugeme2022,
author = {Bugeme, Marcellin and Affognon, Kegnide Christelle Cadnelle and Musung, Jacques Mbaz and Omanjelo, Franck Shongo and Teuwen, Dirk E. and Numbi, Sarah Kilumba and Ndua, Jenny Tshijik and Mukuku, Olivier and Muyumba, Emmanuel Kiyana},
title = {Gilles de la Tourette syndrome in Central Africa: A case report},
journal = {Advances in General Practice of Medicine},
year = {2022},
doi = {10.25082/agpm.2022.01.006}
}
EUVIMED